BWS Financial Initiates Coverage On Twist Bioscience with Sell Rating, Announces Price Target of $45
Benzinga Newsdesk 1 month ago
NewsInitiationAnalyst RatingsPrice Target
BWS Financial analyst Hamed Khorsand initiates coverage on Twist Bioscience (NASDAQ:TWST) with a Sell rating and announces Price Target of $45.
BWS Financial analyst Hamed Khorsand initiates coverage on Twist Bioscience (NASDAQ:TWST) with a Sell rating and announces Price Target of $45.